New Jabs for the Job

FromThe Morning Brief

Start listening View podcast show

New Jabs for the Job

FromThe Morning Brief

ratings:

Length:

23 minutes

Released:

Apr 15, 2021

Format:

Podcast episode

Description

As the second wave of Covid-19 batters the country, the Indian government has approved the use of vaccines authorised in the US, UK, Europe and Japan to combat the dreaded disease. ET's Teena Thacker and Nidhi Sharma tell us about the challenges ahead and how soon will every citizen in India be vaccinated

Released:

Apr 15, 2021

Format:

Podcast episode

Titles in the series (100)

To make sense of the week’s hottest stories in business, economy, politics and markets, journalists from the Economic Times chat with reporters and industry leaders in this thrice-weekly (Tuesday, Thursday, Friday) podcast.

Skip carousel

Shoppers vs Slowdown by The Morning Brief
21 min listen
India's Post-Covid Job Market by The Morning Brief
20 min listen
Post-Covid complications by The Morning Brief
23 min listen
The Russian Vaccine Connection by The Morning Brief
22 min listen
Fuel on Fire by The Morning Brief
22 min listen
The Amazon-Future Group Dispute by The Morning Brief
9 min listen
Ratan Tata's Millennial Assistant by The Morning Brief
30 min listen
Regulating Digital Content by The Morning Brief
20 min listen
The Vedanta Delisting Fiasco by The Morning Brief
15 min listen
Will India ever get its own Ant? by The Morning Brief
16 min listen
Tata-SP Group Negotiations by The Morning Brief
27 min listen
The IPL Economy by The Morning Brief
18 min listen
The Telangana Model by The Morning Brief
59 min listen
Flipkart Goes Shopping by The Morning Brief
1 min listen
Goa's Fine Whisky Connection by The Morning Brief
21 min listen
Harshad For Millenials by The Morning Brief
24 min listen
Vaccine Reality Dose by The Morning Brief
18 min listen
The US Presidential Election by The Morning Brief
21 min listen
Can Jet Fly Again? by The Morning Brief
21 min listen
Singapore Sling for Lakshmi Vilas Bank by The Morning Brief
21 min listen
What’s next for the telecom sector? by The Morning Brief
22 min listen
The India-China Border Conflict by The Morning Brief
35 min listen
Decoding Battleground Bihar by The Morning Brief
26 min listen
Get Shorty by The Morning Brief
25 min listen
Vaccinating a Billion Indians by The Morning Brief
23 min listen
Aatmanirbhar Bharat 3.0: Hit or Miss? by The Morning Brief
26 min listen
War for the planet of the Apps by The Morning Brief
17 min listen
Surgical Strike by The Morning Brief
18 min listen
Farm Furore by The Morning Brief
33 min listen
Are we ready for WhatsApp Pay? by The Morning Brief
22 min listen

More Episodes from The Morning Brief

Skip carousel

'Coffee'nomics - Business Behind The Beans by The Morning Brief
37 min listen
Digital Divide: Who Should Pay for Payments? by The Morning Brief
27 min listen
The Dolo Debate - Is Pharma Paying for Prescriptions? by The Morning Brief
26 min listen
Audio Evolution to Podcasting Revolution by The Morning Brief
23 min listen
Gaming Gladiators and India’s Esports Arena by The Morning Brief
46 min listen
Is your Data Safe on Aarogya Setu? by The Morning Brief
22 min listen
Business Baazigars: Independence Day Special - Part I by The Morning Brief
31 min listen
Business Baazigars: Independence Day Special - Part II by The Morning Brief
31 min listen
Green Light for Moonlighting and more! by The Morning Brief
23 min listen
Mock Meat: Can India develop a taste for it? by The Morning Brief
21 min listen
How Will India Protect its Citizens’ Data? by The Morning Brief
25 min listen
Furrynomics - The Business of Pets by The Morning Brief
25 min listen
Is India Eating Out of Zomato's Hand? by The Morning Brief
31 min listen
Fire or Frying Pan: High Rates or Global Recession? by The Morning Brief
22 min listen
Loans Over Phones: App-solute Menace by The Morning Brief
23 min listen
Socially Acceptable: Influencers Get A Reality Check by The Morning Brief
26 min listen
Diabetes Drugs: Bittersweet Truth of Patent Expiries by The Morning Brief
29 min listen
Plane In A Pickle: SpiceJet's Many Problems by The Morning Brief
26 min listen
Single Use Plastic: Can a Ban Beat it? by The Morning Brief
18 min listen
Adani vs Ambani vs Airtel: The fight for 5G by The Morning Brief
40 min listen
Smuggling Smokes: The Booming Black Market by The Morning Brief
26 min listen
On Air with the Akasa Boys by The Morning Brief
39 min listen
Mission MNCs: Harassed or Hide? by The Morning Brief
27 min listen
Bridging India’s Gender Pleasure Gap by The Morning Brief
26 min listen
Shifting Gears for Safer Cars: The Six Airbags Mandate by The Morning Brief
22 min listen
What's Going on at Byju's by The Morning Brief
28 min listen
The EV Battery Bet: Charged for Change by The Morning Brief
22 min listen
RBI Ain’t Buying BNPL by The Morning Brief
25 min listen
Storm in A Teacup by The Morning Brief
23 min listen
IPL: Does The Math Add Up? by The Morning Brief
28 min listen

Related podcast episodes

Skip carousel

Fighting the Fungi by The Morning Brief
30 min listen
Vaccination Nations: Times Columnists David Aaronovitch and Daniel Finkelstein pick over the days news; then Matt Chorley boards Times Radio airways to find out how the vaccine rollout is going across the globe, from France, to Germany, Israel, Japan the US and China by Politics Without The Boring Bits
40 min listen
To boost or not to boost? Ontario expands fourth shots to all adults: Guest: May Warren, Toronto Star reporter Fourth COVID-19 vaccine doses are now open to all Ontarians older than 18 years of age. Ontario’s chief medical officer of health Dr. Kieran Moore made the much awaited announcement to expand eligibility on... by This Matters
15 min listen
Dr Dicky Budiman - Managing the Omicron Wave: Dr Dicky Budiman - Omicron wave Indonesia has re… by Talking Indonesia
32 min listen
The Lessons Learned And Cultural Shifts Following Covid by The Drill Down with Peter Schweizer
28 min listen
(Vaccine) Jabs at the White House: Vice President Mike Pence received the Pfizer-BioNTech Covid-19 vaccine in a televised appearance today in an effort to boost public confidence in its effectiveness. President-elect Joe Biden could be vaccinated as soon as next week. As the country awaits final approval for Moderna’s Covid-19 vaccine, former FDA Commissioner Dr. Scott Gottlieb raises concerns about the shot supply and volume. CNBC's Meg Tirrell explains the imminent vaccine rollouts that could keep the U.S. on target for its distribution goals. Plus, Jim Cramer joins Joe Kernen and Andrew Ross Sorkin in a Friday chat about resisting social temptation in the pandemic and taking on ConEd in the wee hours. by Squawk Pod
38 min listen
India in Crisis by Chasing Life
11 min listen
The Global Vaccine Gap by Prognosis: Losing it
14 min listen
¿QPM? S6 EP 2: What recovering after COVID-19 looks like for a Latinx with a double-lung transplant: En este episodio, I want you to meet Mayra Ramirez. Mayra contracted the virus and ended up in the ICU on life support. She was 28. by ¿Qué Pasa, Midwest?
13 min listen
Dicky Budiman - The Worsening Covid-19 Crisis: Dicky Budiman: the worsening pandemic crisis We … by Talking Indonesia
42 min listen
Long COVID deep dive, Part 1: ‘You need to grieve the life you thought you were going to live’ by Next Question with Katie Couric
40 min listen
News Roundup - March 24, 2023 by American Prestige
36 min listen
Your Questions About Covid-19 Answered: News and information about the covid-19 virus-how it spreads, how long it lasts in various environments, and best practices to protect ourselves-is constantly changing. Infectious disease specialist Dr. Mia Taormina keeps us up to date, and answers those by Reset with Sasha-Ann Simons
21 min listen
The Coronavirus Goes Global by The Daily
23 min listen
Monkeypolitics [S5, E17]: The emergence of Monkeypox stress-tested the lessons learned during the COVID-19 pandemic – and, again, the world is failing the challenge. Health institutions seem unprepared to deal with this new health scare, especially one that targets a... by Altamar - Navigating the High Seas of Global Politics
29 min listen
Vaccine approval - A licence to kill… COVID: The Pfizer/BioNTech vaccine was the first to announce its success in trials – offering “hope on the horizon” in the fight against the virus. On Wednesday, the UK became the first country in the world to approve its use – with care home residents... by Sky News Daily
32 min listen
The U.S. Approves a Vaccine by The Daily
31 min listen
Covid Treatments & Emergency Use Approvals; Debating to Convince “The Undecideds”: Regeneron and Eli Lilly have both asked the FDA to grant their experimental Covid-19 antibody treatments emergency use approval. President Trump, who received Regeneron’s antibody cocktail in his own coronavirus treatments, is urging regulators to approve them for widespread use. CNBC’s Meg Tirrell breaks down the journey ahead for the treatments with Joe, Becky, and Andrew. Pollster and political strategist Frank Luntz discusses how the 6% of American voters who remain undecided responded to the Vice Presidential debate. Plus, activist investor Dan Loeb is asking Disney to bet even bigger on Disney+. by Squawk Pod
37 min listen
Episode 132: Martin Kulldorff discusses vaccines, lockdowns, school closings and the global response to COVID-19: Martin Kulldorff, COVID-19, vaccines, school closings, lockdowns, mask mandates, Great Barrington Declaration,MMR vaccine,infectious diseases,herd immunity,age-adjusted COVID mortality rate,John Snow Memorandum,CDC,Brownstone Institute,Ken Ford,IHMC by STEM-Talk
94 min listen
The debate and ethics of vaccine boosters: Guest: Kenyon Wallace, investigative reporter for the Toronto Star Amidst a growing fourth wave, the spread of the Delta variant and questions over how long immunity lasts, a number of nations around the world, including the United Kingdom, Germany,... by This Matters
17 min listen
The deadly consequences of an uneven vaccine rollout by The Take
20 min listen
Pharma's reputation and the responsibility of scientific data by #5Things: This Week in Social
27 min listen
Andrea Garcia, JD, MPH, discusses omicron, vaccine mandate challenges and Merck's COVID pill: AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the omicron variant, vaccine mandate challenges and pending FDA authorization for Merck's COVID pill. by AMA Update
14 min listen
How worried should we really be about coronavirus? by Next Question with Katie Couric
52 min listen
FDA-authorized COVID boosters, plus Pirola variant & reinfection studies with Andrea Garcia, JD, MPH: COVID-19 cases continue to rise, and the FDA authorizes new COVID-19 boosters. AMA's Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, also discusses the latest news about the Eris (EG.5) and Pirola (BA.2.86) variants, the effects of COVID-19 reinfection, and its relationship with Long COVID. Plus, the CDC’s health advisory on RSV. American Medical Association CXO Todd Unger hosts. ? The AMA is your powerful ally in patient care. Join now: https://bit.ly/AMAJoinRenew by AMA Update
13 min listen
The News Roundup For October 16, 2020 by 1A
92 min listen
Predicting the Coronavirus Future: Disease modelers are trying to come up with their best guesses about how badly COVID-19 could take hold in the United States. Health reporter Erin Allday discusses what we know and what could stave off the worst possible outcomes. by Fifth & Mission
26 min listen
Andrea Garcia, JD, MPH, discusses EUA requests for boosters and children ages 5-11: AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering COVID-19 vaccine emergency use authorization (EUA) requests from Pfizer for children ages 5-11, as well as movement on boosters for Johnson & Johnson and Moderna vaccine recipients. by AMA Update
14 min listen
Andrea Garcia, JD, MPH, discusses recent EUA for Pfizer's COVID vaccine for 5-11 year olds: AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the FDA's authorization of Pfizer-BioNTech’s coronavirus vaccine for emergency use in children 5 to 11, vaccine mandates in schools, and the AMA's support of the Biden Administration's plan to address the nation's overdose epidemic. by AMA Update
16 min listen
Special Edition: COVID Testing Questions Answered by The NewsWorthy
16 min listen

Discover this podcast and so much more

New Jabs for the Job

New Jabs for the Job

Description

Titles in the series (100)

More Episodes from The Morning Brief

Related podcast episodes